Literature DB >> 15980699

Motivations for participating in an HIV vaccine efficacy trial.

Grant Colfax1, Susan Buchbinder, Goli Vamshidar, Connie Celum, David McKirnan, Judith Neidig, Beryl Koblin, Marc Gurwith, Brad Bartholow.   

Abstract

Understanding why people join HIV vaccine efficacy trials is critical for trial recruitment and education efforts. We assessed participants' motivations for joining the VaxGen VAX004 study, a randomized, double-blind, placebo-controlled, phase 3 multicenter trial. Of 5417 participants, 94% were men who have sex with men (MSM) and 6% were women at risk for heterosexual transmission of HIV. Most participants gave altruistic reasons for trial participation: 99% reported having joined to help find an HIV vaccine, and 98% reported having joined to help their community. Some gave more personal reasons: 56% joined to reduce risk behavior and 46% joined to get protection from HIV. Additional reasons related to receiving services or compensation included to obtain information about HIV (75%), to receive free HIV testing (34%), and for financial reimbursement (14%). Multivariate logistic regression analysis showed that female participants were significantly more motivated than male participants to join the trial for protection and to receive services or compensation (all P<0.05). Participants with 13 or more sex partners in the 6 months before enrollment were more likely than those with fewer sex partners to report having joined the trial for protection but less likely to have joined to reduce risk behavior (both P<0.05). Because many participants reported personal protection from HIV as their reason for joining, vaccine trial risk-reduction counseling should continue to emphasize the placebo-controlled trial design and unknown efficacy of the test product, particularly for women and persons with large numbers of sex partners. Because a significant minority of participants reported joining to receive HIV information, HIV testing, and financial reimbursement, a need is indicated for provision of HIV prevention services outside research trials and for monitoring to ensure that participants are not motivated to join trials for financial gain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15980699     DOI: 10.1097/01.qai.0000152039.88422.ec

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  52 in total

1.  Co-enrollment in multiple HIV prevention trials - experiences from the CAPRISA 004 Tenofovir gel trial.

Authors:  Quarraisha Abdool Karim; Ayesha B M Kharsany; Kasavan Naidoo; Nonhlanhla Yende; Tanuja Gengiah; Zaheen Omar; Natasha Arulappan; Koleka P Mlisana; Londiwe R Luthuli; Salim S Abdool Karim
Journal:  Contemp Clin Trials       Date:  2011-01-26       Impact factor: 2.226

2.  Promoting HIV Vaccine Research in African American Communities: Does the Theory of Reasoned Action Explain Potential Outcomes of Involvement?

Authors:  Paula M Frew; Matthew Archibald; Nina Martinez; Carlos del Rio; Mark J Mulligan
Journal:  Challenge (Atlanta Ga)       Date:  2007

3.  Balancing collective responsibility, individual opportunities and risks: a qualitative study on how police officers reason around volunteering in an HIV vaccine trial in Dar es Salaam, Tanzania.

Authors:  Edith A M Tarimo; Anna Thorson; Thecla W Kohi; Joachim Mwami; Muhammad Bakari; Eric Sandström; Asli Kulane
Journal:  BMC Public Health       Date:  2010-05-28       Impact factor: 3.295

Review 4.  Experiences in recruiting volunteers through community based initiatives in phase-1 vaccine trials in India.

Authors:  Seema Sahay; Makesh Kumar; Aylur K Srikrishnan; Vadakkuppatu Ramanathan; Sanjay Mehendale
Journal:  Hum Vaccin Immunother       Date:  2013-10-18       Impact factor: 3.452

5.  The Motivations and Experiences of Young Women in a Microbicide Trial in the USA and Puerto Rico.

Authors:  Rebecca Giguere; Gregory D Zimet; Jessica A Kahn; Curtis Dolezal; Cheng-Shiun Leu; Marina Mabragaña; Ian McGowan; Alex Carballo-Diéguez
Journal:  World J AIDS       Date:  2013-09

6.  Recruitment of urban US women at risk for HIV infection and willingness to participate in future HIV vaccine trials.

Authors:  Barbara Metch; Ian Frank; Richard Novak; Edith Swann; David Metzger; Cecilia Morgan; Debbie Lucy; Debora Dunbar; Parrie Graham; Tamra Madenwald; Gina Escamilia; Beryl Koblin
Journal:  AIDS Behav       Date:  2013-02

7.  Factors influencing HIV vaccine community engagement in the urban South.

Authors:  Paula M Frew; Carlos del Rio; Sarah Clifton; Matthew Archibald; Joseph T Hormes; Mark J Mulligan
Journal:  J Community Health       Date:  2008-08

8.  In "Step" with HIV Vaccines? A Content Analysis of Local Recruitment Campaigns for an International HIV Vaccine Study.

Authors:  Paula M Frew; Wendy Macias; Kayshin Chan; Ashley C Harding
Journal:  J Health Mass Commun       Date:  2009

9.  Willingness to volunteer in a Phase I/II HIV vaccine trial: a study among police officers in Dar es Salaam, Tanzania.

Authors:  Edith A M Tarimo; Anna Thorson; Muhammad Bakari; Joachim Mwami; Eric Sandström; Asli Kulane
Journal:  Glob Health Action       Date:  2009-08-07       Impact factor: 2.640

10.  Beliefs About Anal Cancer among HIV-Infected Women: Barriers and Motivators to Participation in Research.

Authors:  Tracy A Battaglia; Christine M Gunn; Molly E McCoy; Helen H Mu; Amy S Baranoski; Elizabeth Y Chiao; Lisa A Kachnic; Elizabeth A Stier
Journal:  Womens Health Issues       Date:  2015-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.